Cipla
Pramod Dalvi has extensive experience in quality operations within the pharmaceutical industry, currently serving as the Senior Vice President of Quality Operations at Cipla since August 2018, overseeing operations in Goa, the USA, and SAGA. Prior to this role, Pramod held the position of Vice President of International Quality Operations at Watson Pharma Pvt Ltd from December 2006 to July 2018, focusing on the Asia Pacific region. Earlier in the career, Pramod contributed to quality initiatives at Cipla Ltd from May 1997 to December 2006. Educational qualifications include completion of SSC at Parle Tilak from 1986 to 1987.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.